415 related articles for article (PubMed ID: 21363963)
1. Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A.
Corrionero A; Miñana B; Valcárcel J
Genes Dev; 2011 Mar; 25(5):445-59. PubMed ID: 21363963
[TBL] [Abstract][Full Text] [Related]
2. Spliceostatin A inhibits spliceosome assembly subsequent to prespliceosome formation.
Roybal GA; Jurica MS
Nucleic Acids Res; 2010 Oct; 38(19):6664-72. PubMed ID: 20529876
[TBL] [Abstract][Full Text] [Related]
3. The anti-tumor drug E7107 reveals an essential role for SF3b in remodeling U2 snRNP to expose the branch point-binding region.
Folco EG; Coil KE; Reed R
Genes Dev; 2011 Mar; 25(5):440-4. PubMed ID: 21363962
[TBL] [Abstract][Full Text] [Related]
4. Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA.
Kaida D; Motoyoshi H; Tashiro E; Nojima T; Hagiwara M; Ishigami K; Watanabe H; Kitahara T; Yoshida T; Nakajima H; Tani T; Horinouchi S; Yoshida M
Nat Chem Biol; 2007 Sep; 3(9):576-83. PubMed ID: 17643111
[TBL] [Abstract][Full Text] [Related]
5. Interactions between SAP155 and FUSE-binding protein-interacting repressor bridges c-Myc and P27Kip1 expression.
Matsushita K; Tamura M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Levens D; He L; Liu J; Yoshida M; Nomura F
Mol Cancer Res; 2013 Jul; 11(7):689-98. PubMed ID: 23594796
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of differential 3' splice site sensitivity to anti-tumor drugs targeting U2 snRNP.
Vigevani L; Gohr A; Webb T; Irimia M; Valcárcel J
Nat Commun; 2017 Dec; 8(1):2100. PubMed ID: 29235465
[TBL] [Abstract][Full Text] [Related]
7. Global analysis of pre-mRNA subcellular localization following splicing inhibition by spliceostatin A.
Yoshimoto R; Kaida D; Furuno M; Burroughs AM; Noma S; Suzuki H; Kawamura Y; Hayashizaki Y; Mayeda A; Yoshida M
RNA; 2017 Jan; 23(1):47-57. PubMed ID: 27754875
[TBL] [Abstract][Full Text] [Related]
8. Stem-loop 4 of U1 snRNA is essential for splicing and interacts with the U2 snRNP-specific SF3A1 protein during spliceosome assembly.
Sharma S; Wongpalee SP; Vashisht A; Wohlschlegel JA; Black DL
Genes Dev; 2014 Nov; 28(22):2518-31. PubMed ID: 25403181
[TBL] [Abstract][Full Text] [Related]
9. Spliceostatin A interaction with SF3B limits U1 snRNP availability and causes premature cleavage and polyadenylation.
Yoshimoto R; Chhipi-Shrestha JK; Schneider-Poetsch T; Furuno M; Burroughs AM; Noma S; Suzuki H; Hayashizaki Y; Mayeda A; Nakagawa S; Kaida D; Iwasaki S; Yoshida M
Cell Chem Biol; 2021 Sep; 28(9):1356-1365.e4. PubMed ID: 33784500
[TBL] [Abstract][Full Text] [Related]
10. Herboxidiene Features That Mediate Conformation-Dependent SF3B1 Interactions to Inhibit Splicing.
Gamboa Lopez A; Allu SR; Mendez P; Chandrashekar Reddy G; Maul-Newby HM; Ghosh AK; Jurica MS
ACS Chem Biol; 2021 Mar; 16(3):520-528. PubMed ID: 33617218
[TBL] [Abstract][Full Text] [Related]
11. U2 snRNP is required for expression of the 3' end of genes.
Koga M; Satoh T; Takasaki I; Kawamura Y; Yoshida M; Kaida D
PLoS One; 2014; 9(5):e98015. PubMed ID: 24845214
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and NMR analyses of an SF3b155-p14-U2AF-RNA interaction network involved in branch point definition during pre-mRNA splicing.
Spadaccini R; Reidt U; Dybkov O; Will C; Frank R; Stier G; Corsini L; Wahl MC; Lührmann R; Sattler M
RNA; 2006 Mar; 12(3):410-25. PubMed ID: 16495236
[TBL] [Abstract][Full Text] [Related]
13. A novel U2 and U11/U12 snRNP protein that associates with the pre-mRNA branch site.
Will CL; Schneider C; MacMillan AM; Katopodis NF; Neubauer G; Wilm M; Lührmann R; Query CC
EMBO J; 2001 Aug; 20(16):4536-46. PubMed ID: 11500380
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of intron selection by U2 snRNP in the presence of covalent inhibitors.
Cretu C; Gee P; Liu X; Agrawal A; Nguyen TV; Ghosh AK; Cook A; Jurica M; Larsen NA; Pena V
Nat Commun; 2021 Jul; 12(1):4491. PubMed ID: 34301950
[TBL] [Abstract][Full Text] [Related]
15. Sudemycin E influences alternative splicing and changes chromatin modifications.
Convertini P; Shen M; Potter PM; Palacios G; Lagisetti C; de la Grange P; Horbinski C; Fondufe-Mittendorf YN; Webb TR; Stamm S
Nucleic Acids Res; 2014 Apr; 42(8):4947-61. PubMed ID: 24623796
[TBL] [Abstract][Full Text] [Related]
16. Evidence that the 60-kDa protein of 17S U2 small nuclear ribonucleoprotein is immunologically and functionally related to the yeast PRP9 splicing factor and is required for the efficient formation of prespliceosomes.
Behrens SE; Galisson F; Legrain P; Lührmann R
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8229-33. PubMed ID: 8367487
[TBL] [Abstract][Full Text] [Related]
17. A U2-snRNP-independent role of SF3b in promoting mRNA export.
Wang K; Yin C; Du X; Chen S; Wang J; Zhang L; Wang L; Yu Y; Chi B; Shi M; Wang C; Reed R; Zhou Y; Huang J; Cheng H
Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7837-7846. PubMed ID: 30923118
[TBL] [Abstract][Full Text] [Related]
18. SF3B1 mutations constitute a novel therapeutic target in breast cancer.
Maguire SL; Leonidou A; Wai P; Marchiò C; Ng CK; Sapino A; Salomon AV; Reis-Filho JS; Weigelt B; Natrajan RC
J Pathol; 2015 Mar; 235(4):571-80. PubMed ID: 25424858
[TBL] [Abstract][Full Text] [Related]
19. U2 snRNA structure is influenced by SF3A and SF3B proteins but not by SF3B inhibitors.
Urabe VK; Stevers M; Ghosh AK; Jurica MS
PLoS One; 2021; 16(10):e0258551. PubMed ID: 34648557
[TBL] [Abstract][Full Text] [Related]
20. Combined biochemical and electron microscopic analyses reveal the architecture of the mammalian U2 snRNP.
Krämer A; Grüter P; Gröning K; Kastner B
J Cell Biol; 1999 Jun; 145(7):1355-68. PubMed ID: 10385517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
